Parenteral Nutrition Market Size to Record US$ 11.62 billion by 2032

According to a recent research report titled ” Parenteral Nutrition Market (By Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals; By Stage Type: Adult, Pediatrics; By Indication: Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management; By Sales Channel: Online Sales, Retail Sales) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032″ published by Precedence Research, the global parenteral nutrition market size is projected to touch around USD 11.62 billion by 2032 and growing at a CAGR of 6.2% over the forecast period 2023 to 2032. This comprehensive study examines various factors and their impact on the growth of the parenteral nutrition market.

Key Takeaways

• North America dominated the market with the highest market share of 41% in 2022.
• Asia-Pacific is expected to expand at the fastest CAGR during the forecast period.
• By Nutrient Type, the single-dose amino acid solution segment has held the biggest revenue share of 31% in 2022.
• By Nutrient Type, the trace elements segment is estimated to grow at a notable CAGR of 8.1% during the projected period.
• By Stage Type, the adult segment captured more than 85% of revenue share in 2022.
• By Stage Type, the single touch segment is projected to expand at the fastest CAGR over the projected period.
• By Indication, the other segment contributes the largest revenue share of 31% in 2022.
• By Indication, the alzheimer’s segment is estimated to grow at a remarkable 9.9% over the predicted period.
• By Sales Channel, the institutional sales channel segment generated more than 49% in 2022.
• By Sales Channel, the online sales segment is projected to expand at a remarkable CAGR of 11.8% over the predicted period.

Parenteral Nutrition Market Overview:

The Parenteral Nutrition Market refers to the sector dedicated to the intravenous administration of essential nutrients to individuals who are unable to consume food through the normal digestive process. This method becomes crucial when patients suffer from conditions such as malabsorption, severe gastrointestinal disorders, or are unable to take oral nutrition. The market encompasses a range of products and services aimed at providing a balanced and complete nutritional solution directly into the bloodstream.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3417

Parenteral Nutrition Market Growth Factors:

The Parenteral Nutrition Market is witnessing robust growth due to several factors. The rising prevalence of chronic diseases, an aging population, and an increasing number of patients undergoing surgical procedures are key contributors. Additionally, advancements in parenteral nutrition formulations, improved healthcare infrastructure, and a growing awareness about the benefits of this therapy among healthcare professionals and patients are fueling market expansion. The market’s growth is further propelled by the continuous development of innovative products and technologies.

Parenteral Nutrition Market Scope

Also read: Melanoma Therapeutics Market Size to Record US$ 14.59 Billion by 2032

Major Key Points Covered in the Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides an analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Parenteral Nutrition Market Opportunities:

Opportunities within the Parenteral Nutrition Market are diverse and promising. The increasing demand for personalized nutrition solutions presents a significant opportunity for market players to develop tailored parenteral nutrition formulations based on individual patient needs. Expansion into emerging markets, where healthcare infrastructure is evolving, provides another avenue for growth. Moreover, collaborations between pharmaceutical companies and healthcare providers to enhance the accessibility and affordability of parenteral nutrition products open up new possibilities for market expansion.

Parenteral Nutrition Market Challenges:

Despite its growth, the Parenteral Nutrition Market faces certain challenges. The high cost associated with parenteral nutrition therapy and products can limit accessibility for some patient populations. Regulatory complexities and stringent quality standards add to the challenges faced by market players. Furthermore, addressing concerns related to potential complications such as infections, metabolic imbalances, and catheter-related issues is essential for ensuring the safety and efficacy of parenteral nutrition, posing a challenge in maintaining a balance between therapeutic benefits and risks.

Market Key Players

The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the parenteral nutrition market.

Some of the prominent players in the parenteral nutrition market include

• Baxter
• Allergan
• Actavis Inc.
• Otsuka Pharmaceutical Factory, Inc.
• Grifols, S.A.
• B. Braun Melsungen AG
• Vifor Pharma
• Fresenius Kabi AG
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Pfizer Inc. (Hospira Inc.)

Market Segmentations 

By Nutrient Type

• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins & Minerals

By Stage Type

• Adult
• Pediatrics

By Indication

• Alzheimer’s
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

By Sales Channel

• Online Sales
• Retail Sales
• Institutional Sales

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Table of Contents:

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Parenteral Nutrition Market 

5.1. COVID-19 Landscape: Parenteral Nutrition Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Parenteral Nutrition Market, By Nutrient Type

8.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Nutrient Type, 2023-2032

8.1.1. Carbohydrates

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Parenteral Lipid Emulsion

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Single Dose Amino Acid Solution

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Trace Elements

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Vitamins & Minerals

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Parenteral Nutrition Market, By Stage Type

9.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Stage Type, 2023-2032

9.1.1. Adult

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Pediatrics

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Parenteral Nutrition Market, By Indication 

10.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Indication, 2023-2032

10.1.1. Alzheimer’s

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Nutrition Deficiency

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Cancer Care

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

10.1.4. Chronic Kidney Diseases

10.1.4.1. Market Revenue and Volume Forecast (2020-2032)

10.1.5. Orphan Diseases

10.1.5.1. Market Revenue and Volume Forecast (2020-2032)

10.1.6. Dysphagia

10.1.6.1. Market Revenue and Volume Forecast (2020-2032)

10.1.7. Pain Management

10.1.7.1. Market Revenue and Volume Forecast (2020-2032)

10.1.8. Malabsorption/GI Disorder/Diarrhea

10.1.8.1. Market Revenue and Volume Forecast (2020-2032)

10.1.9. Others

10.1.9.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Parenteral Nutrition Market, By Sales Channel 

11.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Sales Channel, 2023-2032

11.1.1. Online Sales

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Retail Sales

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Institutional Sales

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Parenteral Nutrition Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

Chapter 13. Company Profiles

13.1. Baxter

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Allergan

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Actavis Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Otsuka Pharmaceutical Factory, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Grifols, S.A.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. B. Braun Melsungen AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Vifor Pharma

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Fresenius Kabi AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Sichuan Kelun Pharmaceutical Co., Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Pfizer Inc. (Hospira Inc.)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

This report presents a compelling investment opportunity for those interested in the global parenteral nutrition market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for parenteral nutrition. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.

Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.

Some of the key questions answered in this report:       

• What is the size of the overall Parenteral nutrition market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the Parenteral nutrition market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Parenteral nutrition market?
• What is the Parenteral nutrition market size at the regional and country-level?
• Who are the key market players and their key competitors?
• What are the strategies for growth adopted by the key players in Parenteral nutrition market?
• What are the recent trends in Parenteral nutrition market? (M&A, partnerships, new product developments, expansions)?
• What are the challenges to the Parenteral nutrition market growth?
• What are the key market trends impacting the growth of Parenteral nutrition market?

 

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

---